Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

EJNMMI Research

Table 4 Comparison of the reference and hybrid protocol for different time points of single whole-body planar image acquisition (24 h p. i.: HP24; 48 h p. i.: HP48; 72 h p. i.: HP72); all calculated total bone marrow absorbed doses (D_{BM ← total}) are provided

Patient	D_{BM ← total} RP [mGy/GBq]	D_{BM ← total} HP24 [mGy/GBq]	D_{BM ← total} HP48 [mGy/GBq]	D_{BM ← total} HP72 [mGy/GBq]
Octreotate
P1	12.1	13.2	12.6	12.1
P2	9.6	10.8	10.3	9.6
P3	15.6	17.1	16.2	15.7
P4	11.8	13.5	12.8	12.3
P5	12.7	14.9	14.7	13.4
Median	12.1	13.5	12.8	12.3
PSMA-617
P6	10.2	11.3	9.6	10.1
P7	6.7	8.1	6.7	7.0
P8	16.8	17.1	17.1	16.8
P9	14.2	13.5	13.6	15.1
P10	8.3	10.0	8.1	8.5
Median	10.2	11.3	9.6	10.1